tiprankstipranks
Eagle Pharmaceuticals Inc (EGRX)
OTHER OTC:EGRX
US Market
Holding EGRX?
Track your performance easily

Eagle Pharmaceuticals (EGRX) Cash flow

208 Followers

Eagle Pharmaceuticals Cash Flow

EGRX's free cash flow for Q2 2023 was $-132.00K. For the 2023 fiscal year, EGRX's free cash flow was decreased by $22.63M and operating cash flow was $-126.00K. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -9.32M$ 50.70M$ 28.22M$ 49.50M$ 55.99M$ 53.15M
Investing Cash Flow
$ -23.81M$ -86.83M$ -5.32M$ -18.25M$ -777.00K$ -896.00K
Financing Cash Flow
$ 11.92M$ -6.21M$ -28.39M$ -37.87M$ -24.23M$ -88.12M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 107.96M$ 55.32M$ 97.66M$ 103.16M$ 109.78M$ 78.79M
Income Tax Paid Supplemental Data
$ 37.20M$ 28.41M$ 10.01M$ 6.43M$ 6.67M$ 2.28M
Interest Paid Supplemental Data
$ 4.06M$ 1.73M$ 1.20M$ 2.22M$ 2.48M$ 2.08M
Issuance Of Capital Stock
------
Issuance Of Debt
$ 22.64M$ 11.14M$ -8.00M$ -5.00M$ -6.33M$ -3.75M
Repayment Of Debt
$ -87.36M$ -68.86M$ -8.00M$ -115.00M$ -6.33M$ -3.75M
Free Cash Flow
$ -9.39M$ 50.52M$ 27.90M$ 48.75M$ 55.21M$ 53.01M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Eagle Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis